Antimicrobial Agents Practice Questions

Q: Which of the following is a topical antifungal agent?

Butenafine. ***Butenafine*** - **Butenafine** belongs to the class of **benzylamine antifungals** and is used topically to treat fungal infections such as **tinea pedis (athlete's foot)**, **tinea cruris (jock itch)**, and **tinea corporis (ringworm)**. - Its mechanism of action involves inhibiting **squalene epoxidase**, an enzyme essential for fungal cell membrane synthesis, leading to **ergosterol depletion** and accumulation of squalene, which is toxic to the fungus. *Benzyl benzoate* - **Benzyl benzoate** is primarily used as a **topical scabicide** and **pediculicide**, meaning it targets mites (scabies) and lice. - It works by acting as a **neurotoxin** to these parasites, causing paralysis and death, and is not classified as an antifungal agent. *Brimetenide* - This option appears to be a **misspelling** or **non-existent drug name** in common pharmaceutical contexts. - There is no widely recognized drug with the name **"Brimetenide"** that serves as an antifungal. *Posaconazole* - **Posaconazole** is a **systemic triazole antifungal**, typically administered orally or intravenously for the treatment and prophylaxis of invasive fungal infections in immunocompromised patients. - While it is an antifungal, its primary use is **systemic** rather than topical for treating superficial dermatophyte infections.

Q: Which macrolide is MOST active against Mycobacterium leprae?

Clarithromycin. **Correct: Clarithromycin** - **Clarithromycin** is the most active macrolide against **Mycobacterium leprae**, with significant in-vitro and in-vivo bactericidal activity - It is a preferred macrolide for leprosy treatment, particularly useful as an alternative in multidrug therapy (MDT) regimens - Its efficacy is attributed to its ability to attain **high intracellular concentrations** and effectively inhibit mycobacterial protein synthesis - Superior to other macrolides in terms of potency against *M. leprae* *Incorrect: Azithromycin* - While **azithromycin** possesses some activity against *M. leprae*, its potency is **less than clarithromycin** - It has a longer half-life and good tissue penetration, but is not the most active macrolide for this indication - Sometimes used in leprosy regimens, but not typically cited as the most active macrolide *Incorrect: Roxithromycin* - **Roxithromycin** has demonstrated some activity against *M. leprae* in laboratory settings, but is **not as extensively studied or commonly used** as clarithromycin for leprosy - Its clinical utility for leprosy is less well-established - Not considered first-line among macrolides for this indication *Incorrect: Erythromycin* - **Erythromycin**, the first macrolide discovered, has **limited activity** against *M. leprae* compared to newer macrolides like clarithromycin - Poor bioavailability and more frequent dosing requirements make it less practical - Not considered a primary agent for the treatment of leprosy

Q: Which of the following statements about the primary clinical use of levamisole is true?

It is used against ascariasis and ancyclostomiasis. ***It is used against ascariasis and ancyclostomiasis*** - **Levamisole** is an **anthelmintic drug** primarily used for the treatment of **nematode infections**, specifically **roundworms (Ascaris lumbricoides)** and **hookworms (Ancylostoma duodenale)**. - It works by **paralyzing the worms**, leading to their expulsion in the feces. *It is the levoisomer of tetramisole* - While it is true that **levamisole** is the **levorotatory isomer** of **tetramisole**, this statement describes its chemical structure, not its primary clinical use. - **Tetramisole** itself exists as a **racemic mixture** of both levo and dextro isomers. *It has immunomodulator action* - **Levamisole** does possess **immunomodulatory properties** at lower doses and was historically investigated for conditions like **rheumatoid arthritis** and as an adjuvant in colon cancer. - However, its primary and most widespread clinical use is as an **anthelmintic**, not as an immunomodulator, especially due to concerns about side effects like **agranulocytosis**. *It can kill strongyloides larvae and adult worms* - **Levamisole** is **not effective** against **Strongyloides stercoralis** (threadworms). - The drug of choice for **strongyloidiasis** is typically **ivermectin** or **albendazole**.

Q: What are the active ingredients in Savlon antiseptic?

Cetrimide + Chlorhexidine. ***Cetrimide + Chlorhexidine*** - Savlon antiseptic liquid contains **cetrimide (0.5%)** and **chlorhexidine gluconate (0.1%)** as its active ingredients - This combination provides **broad-spectrum antiseptic activity** with complementary mechanisms - **Cetrimide** acts as a quaternary ammonium compound with surfactant and detergent properties, disrupting bacterial cell membranes - **Chlorhexidine** provides prolonged antimicrobial action by binding to bacterial cell walls and disrupting membrane integrity - This is the **standard formulation** used in Savlon antiseptic liquid *Cetrimide + Chlorhexidine + butyl alcohol* - While cetrimide and chlorhexidine are the active ingredients, **butyl alcohol is not listed as a primary active antiseptic ingredient** in standard Savlon formulation - Butyl alcohol may be present as a **solvent or excipient** but not as an active antiseptic agent *Cetrimide + butyl alcohol* - This combination **omits chlorhexidine**, which is a crucial component for Savlon's antiseptic efficacy - Butyl alcohol is not an active antiseptic ingredient in Savlon *Cetrimide + Cetavlon* - **Cetavlon is a trade name** for preparations containing cetrimide itself, not a separate active ingredient - This option represents a **redundancy** as it essentially lists cetrimide twice under different names

Q: Drug of choice for surgical prophylaxis?

Cefazolin. ***Cefazolin*** - **Cefazolin** is a first-generation cephalosporin that provides excellent coverage against **Staphylococcus aureus** and **coagulase-negative staphylococci**, which are common surgical site pathogens. - Its **longer half-life** allows for less frequent dosing and it achieves good tissue penetration, making it ideal for surgical prophylaxis. *Cefaclor* - **Cefaclor** is a second-generation cephalosporin with a broader spectrum of activity but a **shorter half-life**, which makes it less suitable for sustained prophylactic levels. - It offers good oral bioavailability but is generally **not preferred for intravenous surgical prophylaxis** compared to cefazolin. *Ceftizoxime* - **Ceftizoxime** is a third-generation cephalosporin with **broader gram-negative coverage** than cefazolin, but this is often not necessary for routine surgical prophylaxis. - Its spectrum includes organisms less commonly implicated in surgical site infections, and its use could **contribute to antibiotic resistance** without added benefit. *Cefoperazone* - **Cefoperazone** is a third-generation cephalosporin with good activity against **Pseudomonas aeruginosa** and gram-negative bacteria, often used for more serious or nosocomial infections. - Its **broader spectrum** and higher cost make it less appropriate for standard surgical prophylaxis, where a narrower-spectrum agent like cefazolin is effective and preferred.

Q: Which is the fastest acting anti-malarial drug?

Artether. ***Artether*** - **Artether** is an artemisinin derivative known for its rapid action due to its ability to quickly reduce **parasite biomass**. - It works by producing **free radicals** that damage parasite proteins and membranes, leading to rapid parasitic clearance. *Chloroquine* - **Chloroquine** is a 4-aminoquinoline that works by inhibiting **heme detoxification** in the parasite, but its action is slower compared to artemisinins. - Due to widespread resistance, its efficacy is limited in many regions. *Quinine* - **Quinine** is an alkaloid with proven efficacy and acts by interfering with the parasite's **heme polymerization**. - While effective, its onset of action is not as rapid as that of artemisinin derivatives. *Mefloquine* - **Mefloquine** is a quinoline-methanol derivative used for malaria treatment and prophylaxis. - It has a long half-life and is effective, but its action is slower and it is not considered a rapid-acting drug.

Q: Mechanism of action of Linezolid is

Inhibits peptide bond formation. ***Inhibits peptide bond formation*** - Linezolid is an **oxazolidinone antibiotic** that acts at the **initiation stage of bacterial protein synthesis**. - It binds to the **23S ribosomal RNA** of the 50S subunit, preventing formation of the **70S initiation complex** and thereby **blocking the formation of the first peptide bond**. - This is the **functional mechanism** that defines its antibacterial action. *Inhibits 30S ribosomal subunit* - This mechanism is characteristic of **aminoglycosides** (e.g., gentamicin) and **tetracyclines**, which target the 30S ribosomal subunit. - Linezolid specifically targets the **50S subunit**, not the 30S subunit. *Inhibits 23S ribosome subunit of 50S ribosome* - While this correctly describes Linezolid's **binding site** (23S rRNA of the 50S subunit), it does not specify the **functional consequence** of this binding. - The **mechanism of action** in pharmacology refers to the functional effect, which is **inhibition of peptide bond formation** at the initiation stage. - This option describes "where" the drug acts rather than "what" it does at that site. *Inhibits tRNA translocation on the ribosome* - This is the mechanism of **macrolides** (e.g., erythromycin, azithromycin) and **chloramphenicol**, which block the translocation of peptidyl-tRNA from the A-site to the P-site. - Linezolid acts at the **initiation phase**, not during elongation/translocation.

Q: Typhoid is treated by all except

Erythromycin. ***Erythromycin*** - **Erythromycin** is a macrolide antibiotic primarily effective against Gram-positive bacteria and atypical bacteria. - It has **NO role** in the treatment of typhoid fever as it lacks adequate activity against *Salmonella typhi* and does not achieve therapeutic intracellular concentrations. - Unlike azithromycin (another macrolide), erythromycin has poor intracellular penetration and is **never used** for typhoid. *Ceftriaxone* - **Ceftriaxone** is a third-generation cephalosporin that is highly effective against *Salmonella typhi*. - It is a **first-line treatment** for severe typhoid fever and is preferred in regions with fluoroquinolone resistance. - Dosage: 2-4 g IV daily for 10-14 days. *Amikacin* - **Amikacin** is an aminoglycoside with generally poor intracellular penetration, making it suboptimal for treating intracellular pathogens. - While **not a standard agent** for typhoid, it has been used in **rare cases of extensively drug-resistant (XDR) typhoid** as part of combination therapy, particularly in outbreaks where other options have failed. - It is **not a recommended first-line or routine agent** due to limited efficacy, potential toxicity (nephrotoxicity and ototoxicity), and availability of better alternatives. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone with excellent intracellular penetration and was historically the **first-line oral treatment** for uncomplicated typhoid fever. - Its efficacy against *Salmonella typhi* made it the preferred agent for decades. - However, widespread **fluoroquinolone resistance** has emerged in South Asia, limiting its current use as empirical first-line therapy in many regions.

Q: Which of these is least effective for the treatment of typhoid?

Ciprofloxacin. ***Ciprofloxacin*** - While ciprofloxacin was historically a first-line treatment, increasing rates of **quinolone resistance** among *Salmonella Typhi* isolates in many regions have significantly reduced its effectiveness. - The presence of **mutations** in the *gyrA* gene reduces the susceptibility of the bacteria to fluoroquinolones, making it a less reliable empirical treatment. *Chloramphenicol* - **Chloramphenicol** was one of the earliest effective antibiotics for typhoid fever and remains active against many strains, particularly in regions where resistance has not extensively developed. - Its use is limited by potential severe side effects such as **bone marrow suppression** (aplastic anemia), which makes it a less preferred option when safer alternatives are available. *Ceftriaxone* - **Ceftriaxone**, a third-generation cephalosporin, is often used for the treatment of severe or multidrug-resistant (MDR) typhoid fever due to its good activity against *Salmonella Typhi*. - It is typically administered parenterally, making it suitable for hospitalized patients with serious infections, and boasts a favorable **safety profile**. *Cefixime* - **Cefixime** is an oral third-generation cephalosporin that is effective against *Salmonella Typhi* and is often used for outpatient treatment of uncomplicated typhoid fever. - Its primary advantage is its **oral bioavailability**, which allows for step-down therapy after initial parenteral treatment or as a primary treatment in less severe cases.

Question 1

Which of the following is a topical antifungal agent?

Accepted Answer

Butenafine

Answer

Benzyl benzoate

Answer

Brimetenide

Answer

Posaconazole

Question 2

Which macrolide is MOST active against Mycobacterium leprae?

Accepted Answer

Clarithromycin

Answer

Erythromycin

Answer

Azithromycin

Answer

Roxithromycin

Question 3

Which of the following statements about the primary clinical use of levamisole is true?

Accepted Answer

It is used against ascariasis and ancyclostomiasis

Answer

It has immunomodulator action

Answer

It is the levoisomer of tetramisole

Answer

It can kill strongyloides larvae and adult worms

Question 4

What are the active ingredients in Savlon antiseptic?

Accepted Answer

Cetrimide + Chlorhexidine

Answer

Cetrimide + Chlorhexidine + butyl alcohol

Answer

Cetrimide + butyl alcohol

Answer

Cetrimide + Cetavlon

Question 5

Ivermectin is the drug of choice for which of the following infections?

Accepted Answer

Onchocerciasis (river blindness caused by Onchocerca volvulus)

Answer

Trichuriasis (whipworm infection)

Answer

Loiasis (African eye worm)

Answer

Trichinosis (pork roundworm infection)

Question 6

Drug of choice for surgical prophylaxis?

Accepted Answer

Cefazolin

Answer

Cefaclor

Answer

Ceftizoxime

Answer

Cefoperazone

Question 7

Which is the fastest acting anti-malarial drug?

Accepted Answer

Artether

Answer

Chloroquine

Answer

Quinine

Answer

Mefloquine

Question 8

Mechanism of action of Linezolid is

Accepted Answer

Inhibits peptide bond formation

Answer

Inhibits 30S ribosomal subunit

Answer

Inhibits 23S ribosome subunit of 50S ribosome

Answer

Inhibits tRNA translocation on the ribosome

Question 9

Typhoid is treated by all except

Accepted Answer

Erythromycin

Answer

Amikacin

Answer

Ciprofloxacin

Answer

Ceftriaxone

Question 10

Which of these is least effective for the treatment of typhoid?

Accepted Answer

Ciprofloxacin

Answer

Ceftriaxone

Answer

Chloramphenicol

Answer

Cefixime

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?